Trial intelligence / Profile preview

Photo-responsive Nanozyme for Grade III Radiation Dermatitis in Head and Neck Cancer

NCT07086638Recruiting

Sponsor
West China Hospital of Sichuan University
Start
Jul 2025
Primary completion
May 2026
Countries
1
01

Overview

Open-label, single-arm trial in radiation dermatitis, sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence of grade 3 radiation dermatitis. Started Jul 2025; status: recruiting.

02

Conditions

radiation dermatitis

Beyond the preview

Go deeper on NCT07086638.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07086638.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call